Westwood Holdings Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-111
Closed -$57K 517
2022
Q4
$57K Buy
+111
New +$56.4K ﹤0.01% 519
2020
Q1
Sell
-109
Closed -$33K 437
2019
Q4
$33K Buy
+109
New +$30K ﹤0.01% 508
2019
Q2
Sell
-1,300
Closed -$373K 508
2019
Q1
$373K Hold
1,300
﹤0.01% 363
2018
Q4
$341K Hold
1,300
﹤0.01% 359
2018
Q3
$356K Buy
+1,300
New +$337K ﹤0.01% 362

Other funds holding ELV

Westwood Holdings Group's ELV Position: Q1 2023 in Review

Westwood Holdings Group sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 111 shares — an estimated $57K sold.

Westwood Holdings Group first reported a position in ELV in Q3 2018 and held it in 5 quarters. The position peaked at $373K in Q1 2019. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Westwood Holdings Group reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 111 Elevance Health shares in Q1 2023, an estimated $57K.
  • Westwood Holdings Group first reported a position in Elevance Health in Q3 2018 and held it in 5 quarters.
  • Westwood Holdings Group's Elevance Health position peaked at $373K in Q1 2019.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.